UC Davis Health will integrate Propeller Health's remote monitoring platform into its own electronic health record (EHR) system in an effort to offer personalized treatment for high-risk patients with asthma and COPD.
Nebulizing medication for pediatric patients is an effective maintenance therapy for chronic lung conditions like asthma or cystic fibrosis; and yet medication adherence remains a major concern.
Nebulized magnesium with albuterol does not significantly decrease the hospitalization rate of children who present at the emergency department for asthma.
Researchers believe the COVID-19 pandemic may have influenced increases in medication adherence for patients with asthma and COPD between January and March 2020.
Read More
Research into common asthma aerosol treatments could improve therapeutics in the future, according to a study published in European Journal of Pharmaceutics and Biopharmaceutics.
Read More
The US FDA has approved the first generic metered dose inhaler of Proventil HFA (albuterol sulfate), manufactured by Cipla Ltd.
Read More
Asthma specialists are suggesting that patients keep using their preventive inhalers during the coronavirus pandemic, despite an increase in demand.
Read More
As the number of COVID-19 cases grow, hospitals throughout the US are reporting shortages of albuterol, a life saving medication for asthma sufferers.
Read More
A once-daily inhaler combination of fluticasone furoate, umeclidinium and vilanterol reduced overall mortality in patients with chronic obstructive pulmonary disease (COPD) by 42%.
Read More
Nearly 3-in-4 of emerging adults with asthma do not adhere to their prescribed inhaled corticosteroid therapy, according to a study published in the Journal of Asthma.
Read More
A study published in the Journal of the Formosan Medical Association found that bilevel positive airway pressure (BiPAP) ventilation is safe for improving respiratory rate and oxygenation in asthmatic children.
Read More
A survey published in CHEST shows demographic data and clinical characteristics of asthma patients.
Read More
Children with asthma are at much greater risk for invasive pneumococcal disease (IPD), even if they have received the pneumococcal conjugate vaccine (PCV), a systematic review and meta-analysis have found.
Read More
Swiss drugmaker Novartis on Monday said it is jettisoning what it had hoped would be a billion-dollar-selling asthma drug, fevipiprant, from its development program after the medicine failed another set of key trials.
Read More
Chronic lung conditions such as asthma require aerosolized pharmacological maintenance therapy, but data suggests the frequency and dosages can often be overprescribed and based on empirical assumptions rather than clinical evidence.
Read More